Onco-BCG Vaccine 40mg In Pakistan
| Product ID: | onlinetrade_812173 | |||
| Brand: | Onco-BCG Vaccine 40mg | |||
| Shipping: | Rs. 200 (All Over Pakistan) | |||
| Contact Us | 03000950301 | |||
Onco-BCG 40 mg/mL — BCG Immunotherapy
Onco-BCG 40 mg/mL is a specialized Bacillus Calmette-Guérin (BCG) immunotherapy used primarily for the treatment of non-muscle-invasive bladder cancer (NMIBC). It contains live attenuated Mycobacterium bovis and works by stimulating a local immune response within the bladder.
Onco-BCG is different from the routine BCG vaccine used for tuberculosis prevention. It is intended specifically for bladder cancer immunotherapy and must be administered by trained healthcare professionals.
Product Details
| Feature | Details |
|---|---|
| Product Name | Onco-BCG |
| Active Ingredient | Bacillus Calmette-Guérin (BCG) |
| Strength | 40 mg/mL |
| Dosage Form | Lyophilized powder for reconstitution |
| Route | Intravesical administration |
| Therapeutic Class | Antineoplastic immunotherapy |
| Primary Use | Non-muscle-invasive bladder cancer |
| Manufacturer | Serum Institute of India Ltd. |
| Availability | Pakistan |
Indications
Onco-BCG is primarily used for non-muscle-invasive bladder cancer, particularly following transurethral removal of bladder tumors.
It may be used to:
- Reduce the risk of bladder cancer recurrence
- Reduce the risk of disease progression in appropriate high-risk patients
- Provide adjuvant immunotherapy following tumor removal
Treatment suitability is determined by a urologist or oncology specialist.
How Does Onco-BCG Work?
After being introduced into the bladder, BCG stimulates the body's immune system and produces a local inflammatory response. This immune activation helps the body recognize and destroy residual cancer cells within the bladder.
Administration
Onco-BCG is administered intravesically, meaning the prepared solution is introduced directly into the bladder through a urinary catheter.
It is not intended for intravenous, intramuscular, or subcutaneous injection.
The treatment schedule is determined by the treating urologist and may involve an initial course followed by maintenance therapy.
Strength & Presentation
Onco-BCG 40 mg/mL is supplied as a sterile preparation requiring reconstitution before administration.
The exact vial contents, reconstitution volume, viable organism count, and preparation procedure should be confirmed from the manufacturer's current package insert.
Important Precautions
Because Onco-BCG contains live attenuated mycobacteria, it must be handled and administered carefully.
Treatment may be delayed or contraindicated in certain situations, including:
- Active urinary tract infection
- Significant hematuria
- Traumatic catheterization
- Certain immune-suppressive conditions
- Active tuberculosis
- Recent bladder procedures before adequate healing
A healthcare professional should assess the patient before treatment.
Possible Side Effects
Common reactions may include:
- Burning or discomfort during urination
- Increased urinary frequency
- Urinary urgency
- Mild blood in the urine
- Fatigue
- Fever
- Flu-like symptoms
Rarely, serious systemic BCG infection can occur and requires urgent medical attention.
Storage
Onco-BCG should be stored according to the manufacturer's specified storage conditions. Because it contains live attenuated organisms, appropriate cold-chain handling and professional preparation are important.
Please check the product packaging for the exact storage temperature and handling instructions.
Availability in Pakistan
Onco-BCG 40 mg/mL is available in Pakistan through specialized pharmaceutical suppliers.
For purchasing and availability information, customers can check OnlineTrade.pk for the current product listing, stock status, and ordering details.
Important Notice
Onco-BCG is a prescription hospital-use product and should only be administered under the supervision of a qualified urologist or oncology professional. It should not be confused with the BCG vaccine routinely administered to children for tuberculosis prevention.












































































